1. Home
  2. MGIC vs PCRX Comparison

MGIC vs PCRX Comparison

Compare MGIC & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Magic Software Enterprises Ltd.

MGIC

Magic Software Enterprises Ltd.

HOLD

Current Price

$27.44

Market Cap

990.3M

Sector

Technology

ML Signal

HOLD

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$23.59

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MGIC
PCRX
Founded
1983
2006
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
990.3M
1.0B
IPO Year
1991
2011

Fundamental Metrics

Financial Performance
Metric
MGIC
PCRX
Price
$27.44
$23.59
Analyst Decision
Buy
Strong Buy
Analyst Count
2
7
Target Price
$18.00
$32.86
AVG Volume (30 Days)
37.3K
882.7K
Earning Date
11-18-2025
02-26-2026
Dividend Yield
2.25%
N/A
EPS Growth
16.15
N/A
EPS
0.81
0.47
Revenue
$603,216,000.00
$716,791,000.00
Revenue This Year
$12.87
$6.24
Revenue Next Year
$6.23
$9.53
P/E Ratio
$33.10
$55.21
Revenue Growth
12.65
3.14
52 Week Low
$11.36
$18.18
52 Week High
$27.44
$27.64

Technical Indicators

Market Signals
Indicator
MGIC
PCRX
Relative Strength Index (RSI) 61.34 40.40
Support Level $26.77 $24.20
Resistance Level $27.31 $26.48
Average True Range (ATR) 0.55 1.06
MACD -0.05 -0.23
Stochastic Oscillator 98.71 29.39

Price Performance

Historical Comparison
MGIC
PCRX

About MGIC Magic Software Enterprises Ltd.

Magic Software Enterprises Ltd is a software development company. The company's operating segment includes Software Services and IT Professional Services. The company generates maximum revenue from the IT Professional Services segment. IT Professional Services segment offers IT services in the areas of infrastructure design and delivery, application development, technology planning and implementation services, communications services and solutions, as well as supplemental outsourcing services. Geographically, it derives a majority of revenue from the United States and also has a presence in Israel, Europe, Japan, and Other countries.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: